Sun Pharmaceuticals Industries Ltd EGM

Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis

 Copy Link

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million

 Copy Link

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend

 Copy Link

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Sun Pharma reports Q2 net profit at ₹3,040 Crore

 Copy Link

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Sun Pharma's Hair Loss Drug Approved by USFDA

 Copy Link

The US Food and Drug Administration (USFDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets, according to a regulatory filing.

Mayne Pharma Sues Sun Pharma in Patent Dispute

 Copy Link

IMVEXXY is a vaginal insert designed to lessen pain during sexual activity after menopause which is manufactured by Mayne Pharma.

USFDA grills Sun Pharma for manufacturing issues at Dadra facility

 Copy Link

The warning letter detailed substantial violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals at the facility.